ストックスクリーナーアプリを入手
0.4554
2.22%
0.0054
Aditxt Inc (ADTX) 最新ニュース
In the Green: Aditxt Inc (ADTX) Closes at 0.45, Up/Down -10.00 from Previous Day - The Dwinnex
A Closer Look at Aditxt Inc (ADTX) Stock Gains - The InvestChronicle
Aditxt, Inc. Outlines Growth Strategies at Global Investment Conference - TipRanks
BioMedNewsBreaks — Aditxt Inc. (NASDAQ: ADTX) Enters into Second Amendment to Amended and Restated Merger Agreement with Evofem - Kalkine Media
Aditxt Says Will Provide $1.5 Mln Of Financing By Sept 30, Additional $1.5 Mln By Oct 31 - XM
Aditxt, Evofem enter second amendment to plan of merger - TipRanks
Aditxt and Evofem Sign Second Amendment to Amended and Restated Merger Agreement, Target Closing of Acquisition in Fourth Quarter of 2024 - Quantisnow
Aditxt Inc: Rising -98.90% from 52-Week Low, Can the Stock Stay Afloat? - The InvestChronicle
ADTX stock touches 52-week low at $0.54 amid market challenges - Investing.com
Aditxt subsidiary seeks $2M for prostate cancer test - Investing.com
ADTX stock touches 52-week low at $0.54 amid market challenges - Investing.com UK
Aditxt Subsidiary Pearsanta Submits a Grant Application Seeking to Advance Clinical Trials for Mitomic® Prostate Test, Targeting Early Detection in High-Risk Patients - StockTitan
ADTX stock touches 52-week low at $0.54 amid market challenges - Investing.com India
Is Aditxt Inc (ADTX) worth investing in despite its overvalued state? - US Post News
Prepare Yourself for Liftoff: Aditxt Inc (ADTX) - SETE News
Ratio Examination: Aditxt Inc (ADTX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Aditxt to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 9th-11th, 2024 - Quantisnow
Aditxt extends senior note maturity to September 30 By Investing.com - Investing.com Australia
Aditxt extends senior note maturity to September 30 By Investing.com - Investing.com Canada
Aditxt extends senior note maturity to September 30 - Investing.com
Aditxt extends senior note maturity to September 30 By Investing.com - Investing.com UK
Aditxt Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - The InvestChronicle
Stock Market Recap: Aditxt Inc (ADTX) Concludes at 0.79, a -11.70 Surge/Decline - The Dwinnex
Pearsanta appoints Christopher Mitton as President By Investing.com - Investing.com Australia
Pearsanta appoints Christopher Mitton as President - Investing.com
Pearsanta appoints Christopher Mitton as President By Investing.com - Investing.com Canada
Pearsanta appoints Christopher Mitton as President - Investing.com India
ADTXAditxt, Inc. Latest Stock News & Market Updates - StockTitan
Aditxt's Precision Health Subsidiary, Pearsanta, Appoints Christopher Mitton as President as it Seeks to Complete Clinical Validation Studies for its Mitomic® Endometriosis Test (MET™) and Mitomic® Prostate Test (MPT™) - Quantisnow
Pearsanta appoints Christopher Mitton as President By Investing.com - Investing.com UK
Aditxt’s Precision Health Subsidiary, Pearsanta, Appoints Christopher Mitton as President as it Seeks to Complete Clinical Validation Studies for its Mitomic® Endometriosis Test (MET™) and Mitomic® Prostate Test (MPT™) - Elk Valley Times
Aditxt’s Precision Health Subsidiary, Pearsanta, Appoints Christopher Mitton as President as it Seeks to Complete Clinical Validation Studies for its Mitomic® Endometriosis Test (MET™) and Mitomic® Prostate Test (MPT™) - StockTitan
ADTX stock touches 52-week low at $0.88 amid market challenges - Investing.com Australia
500: Something went wrong - Investing.com India
ADTX stock touches 52-week low at $0.88 amid market challenges - Investing.com
ADTX stock touches 52-week low at $0.88 amid market challenges - Investing.com UK
Aditxt extends Appili acquisition deadline to November 19 - Investing.com
Evofem Biosciences amends merger agreement with Aditxt By Investing.com - Investing.com Australia
Aditxt extends Appili acquisition deadline to November 19 By Investing.com - Investing.com Australia
Aditxt extends Appili acquisition deadline to November 19 By Investing.com - Investing.com UK
ADTX’s Stock Dilemma: Aditxt Inc’s Market Performance and Outlook - The InvestChronicle
Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics - Elk Valley Times
Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics - Quantisnow
Appili Therapeutics Modifies Acquisition Deal with Aditxt - TipRanks
Market Update: Aditxt Inc (ADTX) Sees Negative Movement, Closing at 0.95 - The Dwinnex
Appili Therapeutics Announces Third Amendment to Arrangement Agreement and Provides Updated on Transaction with Aditxt - Yahoo Finance
Evofem Biosciences amends merger agreement with Aditxt - Investing.com
Evofem Biosciences amends merger agreement with Aditxt By Investing.com - Investing.com UK
ADTX Stock Earnings: Aditxt Reported Results for Q2 2024 - MSN
ADTX Stock Earnings: Aditxt Reported Results for Q2 2024 - InvestorPlace
Aditxt (NASDAQ:ADTX) Stock Quotes, Forecast and News Summary - Benzinga
Short Interest in Aditxt, Inc. (NASDAQ:ADTX) Increases By 81.5% - Defense World
Evofem Biosciences Announces Financial Results for the Second Quarter of 2024 - StreetInsider.com
Evofem Biosciences Announces Financial Results for the Second Quarter of 2024 - StockTitan
Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2025 - BioSpace
Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2025 - StockTitan
Aditxt shareholders approve strategic proposals - Investing.com
Aditxt shareholders approve strategic proposals - Investing.com India
Aditxt shareholders approve strategic proposals By Investing.com - Investing.com Australia
Aditxt Announces the Successful Passage of all Proposals at Recent Annual Shareholders' Meeting, Setting the Stage for 2024 and 2025 Strategic Plans - Quantisnow
The Psychology of Aditxt Inc Inc. (ADTX) Price Performance: Understanding Market Sentiment - The InvestChronicle
Aditxt Announces the Successful Passage of all Proposals at Recent Annual Shareholders’ Meeting, Setting the Stage for 2024 and 2025 Strategic Plans - StockTitan
A closer look at Aditxt Inc (ADTX) is warranted - US Post News
Aditxt closes USD 1.2M registered direct offering - Medical Buyer
Aditxt secures $1.2 million in registered direct offering - Investing.com India
Aditxt Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - StockTitan
Aditxt secures $1.2 million in registered direct offering - Investing.com
Aditxt Announces $1.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - StockTitan
Aditxt Inc (ADTX) can make a big difference with a little luck - SETE News
Aditxt swaps pre-funded warrants for preferred stock and new warrants - Investing.com India
1.19%
1.65%
大文字化:
|
ボリューム (24 時間):